Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-08-02
1980-04-29
Randolph, John D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260559A, A61K 31165, C07C10322
Patent
active
042006520
ABSTRACT:
Novel 1-aryloxy-3-carbamoylalkylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess .beta.-adrenergic blocking activity. Representative of the compounds disclosed is 1-(2-cyanophenoxy)-3-.beta.-(N-2-furfurylcarbamoyl)ethylamino-2-propanol.
REFERENCES:
patent: 3663607 (1972-05-01), Barrett et al.
patent: 3793365 (1974-02-01), Winter et al.
Large Michael S.
Smith Leslie H.
Imperial Chemical Industries Limited
Randolph John D.
LandOfFree
Alkanolamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkanolamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkanolamine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1684134